IP Library Granted Patent US 9,566,071
Granted Patent B2
US 9,566,071 · App. 14/224,390 · Granted Feb 14, 2017

Systems and devices for cerebral aneurysm repair

Inventors: Randall Takahashi (Irvine, CA); David Ferrera (Coto de Caza, CA)
Assignee: BLOCKADE MEDICAL, LLC
A61B17/12113A61B17/12109A61B17/12145A61B17/12154A61L31/022A61L31/088A61L31/18A61B2017/00893A61B2017/1209A61B2017/12063A61B2090/3966A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,566,071
App. No.
14/224,390
Granted
Feb 14, 2017
Kind
B2
Abstract

An embolization device for treating ischemic stroke is disclosed, having a surface, wherein the body portion is configured to have a radiopaque and electropositive surface under physiological conditions when the device is emplaced, which ionically binds a blood component in an amount effective to promote stability of device in situ to bind to a tissue component in an amount effective to increase adhesion of the device as compared to a device without an electropositive surface. Embolic coils being so delivered are electrolytically detachable in under 10 seconds, according to the disclosed vascular implant systems.

Claims (14)

1. A vascular implant system, comprising, in combination:

an implant assembly including an elongate pushing member having a proximal end and a distal end, an implant coupled to the distal end of the elongate pushing member, and an electrolytically detachable zone proximate the distal end of the elongate pushing member, the electrolytically detachable zone comprising a stainless steel wire having a diameter at the electrolytically detachable zone of between about 0.0015″ and about 0.0025″ and having an electrolytically detachable zone length of between about 0.002″ and 0.008″, wherein the implant is configured to be electrolytically detachable from elongate pushing member at the electrolytically detachable zone;

an electrical power supply configured to electrically couple to the implant assembly at the proximal end of the elongate pushing member, the electrical power supply having a voltage of between about 11.5V and about 17.0V and configured to operate at a current between about 1.4 mA and about 2.4 mA, whereby electrolytic detachment is achieved in less than about 10 seconds.

2. The vascular implant system of claim 1 , wherein the stainless steel wire is electrically insulated along its length except for the electrolytically detachable zone and a terminal zone at the proximal end of the elongate pushing member.

3. The vascular implant system of claim 1 , wherein the electrical power supply comprises a direct current source.

4. The vascular implant system of claim 1 , further comprising:

a polymeric tubular member having a proximal end and a distal end, the polymeric tubular member surrounding the stainless steel wire proximal and adjacent to the electrolytically detachable zone.

5. The vascular implant system of claim 1 , further comprising:

a coating of electrically insulative material surrounding the stainless steel wire immediately adjacent the distal end of a polymeric tubing member,

wherein the coating is applied in a flowable state and then transformed into a substantially non-flowable state.

6. The vascular implant system of claim 1 , further comprising:

a sterile cable configured to connect the electrical power supply to the implant assembly, the sterile cable comprising a sterile button, wherein tactile operation of the sterile button activates the electrical power supply; and,

wherein tactile operation of the sterile button deactivates the electrical power supply, whereby electrolytic detachment is achieved in less than 10 seconds.

7. The vascular implant, system of claim 6 , wherein the implant is a vasooclusive coil, and a detachment time ranges from about 7 to approximately 10 seconds.

Assignments (9)
SECURITY INTEREST Recorded Jun 20, 2025
From: BALT USA, LLC
To: GLAS SAS
Reel/Frame 071474/0638 →
SECURITY INTEREST Recorded Jun 20, 2025
From: BALT USA, LLC
To: GLAS SAS
Reel/Frame 071474/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2025
From: BLOCKADE MEDICAL LLC
To: BALT USA, LLC
Reel/Frame 071031/0393 →
RELEASE OF SECURITY INTEREST Recorded Aug 17, 2016
From: SILICON VALLEY BANK
To: BLOCKADE MEDICAL LLC
Reel/Frame 039470/0462 →
RELEASE OF SECURITY INTEREST Recorded Aug 17, 2016
From: VENTURE LENDING & LEASING VI, INC.; VENTURE LENDING & LEASING VII, INC.
To: BLOCKADE MEDICAL LLC
Reel/Frame 039470/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2016
From: TAKAHASHI, RANDALL; FERRERA, DAVID
To: BLOCKADE MEDICAL, LLC
Reel/Frame 039165/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2014
From: TAKAHASHI, RANDALL; FERRERA, DAVID
To: BLOCKADE MEDICAL, LLC
Reel/Frame 034070/0263 →
SECURITY INTEREST Recorded Jun 17, 2014
From: BLOCKADE MEDICAL LLC
To: SILICON VALLEY BANK
Reel/Frame 033188/0710 →
SECURITY INTEREST Recorded Jun 12, 2014
From: BLOCKADE MEDICAL LLC
To: VENTURE LENDING & LEASING VI, INC.; VENTURE LENDING & LEASING VII, INC.
Reel/Frame 033135/0132 →
Continuity (1)
Related Publication 20140207180A1 · Jul 24, 2014